Bruno Silva Santo
Bruno Silva Santo is a prominent researcher in the field of immunotherapy, particularly known for his work on the innovative DOT cell therapy aimed at treating colorectal cancer. As a co-author of a groundbreaking study published in Nature Cancer, he contributed to demonstrating the efficacy of this therapy, which enhances the power of specific white blood cells to target and eliminate tumors. His research, conducted at the Gulbenkian Institute of Molecular Medicine in Lisbon, has been pivotal in developing potential treatments that could significantly improve outcomes for patients with colorectal cancer, one of the most common and lethal cancers in Spain.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Venezuela | 1 | 9.00 | 0.07% | +0% | 28,435,943 | 20,458 | $48,000 | 35$ |
| Paraguay | 1 | 9.00 | 0.06% | +0% | 7,132,538 | 4,039 | $38,000 | 22$ |
| Totals | 2 | 35,568,481 | 24,497 | $86,000 | 57$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Paraguay:
Bruno Silva Santo is the co-author of the study and developed the cellular therapy using DOT cells.
9
Venezuela:
Bruno Silva Santo developed the cellular therapy used in the study.
9